Hemlibra
Active substance: emicizumab
INJECTION, SOLUTION · EMICIZUMAB 12 mg/.4mL
United StatesActive
Marketing holder: Genentech, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- EMICIZUMAB · 12 mg/.4mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-6ad0-7618-a507-67d572b247d1,01a1208c-6ad2-73b8-8f08-0c37f3dc9ded,01a12091-b67b-7804-9889-9c48ea153690,01a12093-93c7-7c79-a827-b5d7768f6f11,01a1209d-6da5-74ef-a26e-e2ee84cb522d;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50242-927
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 50242-927 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50242-927 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50242-927 · Verified 2026-10-09 · open in source